Ocular Therapeutix: Q2 Earnings Snapshot

Associated Press Finance
1 min read
0
In this article:

BEDFORD, Mass. (AP) — BEDFORD, Mass. (AP) — Ocular Therapeutix Inc. (OCUL) on Monday reported a loss of $20.7 million in its second quarter.

On a per-share basis, the Bedford, Massachusetts-based company said it had a loss of 26 cents. Losses, adjusted for non-recurring gains, came to 27 cents per share.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 29 cents per share.

The biotechnology company posted revenue of $15.2 million in the period, also exceeding Street forecasts. Four analysts surveyed by Zacks expected $14.6 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCUL at https://www.zacks.com/ap/OCUL

Advertisement

Recommended Stories